Evidence map›Paper›PMID 32565869›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Protective Impacts of

Mohamed Mohamed Soliman, Saad Hommod Al-Osaimi, Essam HassanMohamed, Adil Aldhahrani, Adel Alkhedaide, Fayez Althobaiti, Wafaa Abdou Mohamed

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Toxicity Profile ofBiochemistry research international · 2025
    Article
  5. Review
  6. International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mohamed Mohamed SolimanClinical Laboratory Sciences Department, Turabah University College, Taif University, Taif 21995, Saudi Arabia.ORCID https://orcid.org/0000-0001-7208-7123
Saad Hommod Al-OsaimiChemistry Department, Turabah University College, Taif University, Taif 21995, Saudi Arabia.
Essam HassanMohamedDepartment of Biology, Turabah University College, Taif University, Taif 21995, Saudi Arabia.ORCID https://orcid.org/0000-0002-8858-9467
Adil AldhahraniClinical Laboratory Sciences Department, Turabah University College, Taif University, Taif 21995, Saudi Arabia.
Adel AlkhedaideClinical Laboratory Sciences Department, Turabah University College, Taif University, Taif 21995, Saudi Arabia.
Fayez AlthobaitiDepartment of Biotechnology, College of Science, Taif University, Taif, Saudi Arabia.
Wafaa Abdou MohamedClinical Pathology Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Taif University · SAZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe current study was aimed to examine the possible ameliorative impacts of MO leaf extract (MOLE) against MTX-induced alterations on oxidative stress of mouse spleen and explore the possible molecular mechanism that controls such impacts.

methodsAdult male mice were allocated into 4 groups: control,

resultsAs compared with the MTX-injected group, MOLE effectively reduced the changes in total proteins, spleen MDA, SOD and catalase activities, and changes in serum antioxidants levels. Moreover, there is downregulation of antioxidant genes (SOD and catalase) and antiapoptotic genes (XIAP and Bcl-xl) along with upregulation in Bax and caspase-3 mRNA (apoptotic genes) in the MTX-injected group. MTX induced changes in IL-1

conclusionCurrent findings indicated that pretreatment with MOLE to MTX-intoxicated mice showed the potential usage of MO for oxidative stress and apoptosis treatment.

Identifiers

PMID32565869
PMCPMC7275960
OpenAlexW3031029973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.